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Abstract
T cell-dependent autoimmune diseases are characterized by the expansion of T cell clones that recognize immunodominant
epitopes on the target antigen. As a consequence, for a given autoimmune disorder, pathogenic T cell clones express T cell
receptors with a limited number of variable regions that define antigenic specificity. Qa-1, a MHC class I-like molecule,
presents peptides from the variable region of TCRs to Qa-1-restricted CD8+ T cells. The induction of Vß-specific CD8+ T cells
has been harnessed in an immunotherapeutic strategy known as the ‘‘T cell vaccination’’ (TCV) that comprises the injection
of activated and attenuated CD4+ T cell clones so as to induce protective CD8+ T cells. We hypothesized that Qa-1-restricted
CD8+ regulatory T cells could also constitute a physiologic regulatory arm of lymphocyte responses upon expansion of
endogenous CD4+ T cells, in the absence of deliberate exogenous T cell vaccination. We immunized mice with two types of
antigenic challenges in order to sequentially expand antigen-specific endogenous CD4+ T cells with distinct antigenic
specificities but characterized by a common Vß chain in their TCR. The first immunization was performed with a non-self
antigen while the second challenge was performed with a myelin-derived peptide known to drive experimental
autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis. We show that regulatory Vß-specific Qa-1-
restricted CD8+ T cells induced during the first endogenous CD4+ T cell responses are able to control the expansion of
subsequently mobilized pathogenic autoreactive CD4+ T cells. In conclusion, apart from the immunotherapeutic TCV, Qa-1-
restricted specialized CD8+ regulatory T cells can also be induced during endogenous CD4+ T cell responses. At variance
with other regulatory T cell subsets, the action of these Qa-1-restricted T cells seems to be restricted to the immediate re-
activation of CD4+ T cells.
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Introduction
The regulatory potential of Qa-1-restricted CD8+ T cells has been
harnessed in the immunotherapeutic strategy known as the T cell
vaccination (TCV; [1]). The experimental procedure of TCV
comprises the injection of activated, attenuated, T cell clones
expressing one particular Vß sequence in their TCR. Such an
administration leads to the expansion of regulatory suppressive CD8+
T cells that detect Vß peptides derived from the non-hypervariable
region of the TCR (that is not directly involved in antigen
recognition) presented by Qa-1 molecules on the vaccinating cells
[2]. Once expanded these regulatory T cells can recognize and
specifically target activated autoreactive T cells that express similar
Vß chains. Surprisingly, the involvement of such regulatory Qa-1-
restricted CD8+ T cells has never been assessed in a pathophysio-
logical situation where a first CD4+ Vß-dominant immune response
would be followed by a second CD4+T cellresponse involving clones
expressing a TCR of the same Vß family. In other words, can the
regulatory Qa-1-restricted CD8+ T cells triggered upon a first CD4+
T cell response impede a second CD4+ Tc e l lr e s p o n s ei fb o t hC D 4 +
T cell responses mobilize clones belonging to the same Vß family?
To address this question, we used sequential antigenic
immunization procedures. During the first immunization, we
aimed at expanding Qa-1-restricted CD8+ T cells specific for
CD4+ T cells directed against non-self antigens. We then tested
whether the Qa-1-restricted CD8+ T cells induced upon the first
CD4+ T cell response could control a second CD4+ T cell
response implicated in the pathogenesis of murine experimental
autoimmune encephalomyelitis (EAE). In our experimental design,
the two sequential CD4+ T cell responses employed lymphocytes
belonging to the same Vß family.
Our data show that, apart from the immunotherapeutic T cell
vaccination procedure, Qa-1-restricted CD8+ T specialized
regulatory T cells can also be induced by endogenous CD4+ T
cell responses. Furthermore, an unforeseen level of regulation of
the T cell responses is unraveled by our findings, which support
the hypothesis of a continuous reshaping of the regulatory T cell
repertoire dictated by previous CD4+ T cell responses.
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Mice
Six-week old female C57BL/6 (H-2K
b, Qa-1
b) mice were
purchased from Janvier Laboratories. Generation of Qa-1-
deficient mice (H-2K
b) has been previously described [3]. During
the course of the experimentation, all mice were maintained in
pathogen-free conditions and mice were handled in accordance
with European Union directives (86/609/EEC) on the care and
use of laboratory animals. The investigation was approved by the
Animal Ethics Committee of the Institut National de la Sante ´e td e
la Recherche Me ´dicale. The review and approval of the study was
also obtained by the Local Animal Ethics Committee - Comite
d’ethique Bichat/Debre’ (No. B 7518 03).
Immunization with peptide antigens
Six week-old female C57BL/6 (Janvier, France) mice were
immunized with 100 mg of 50V Pigeon Cytochrome C (AEGF-
SYTVANKNKGIT, NeoMPS) or chicken Ovalbumin (OVA,
Sigma) in emulsion with Complete Freund’s Adjuvant (CFA,
Sigma). A final volume of 200 ml was injected subcutaneously at
four different points on the flanks. Control mice were immunized
with PBS in emulsion with CFA.
Induction of EAE
EAE was actively induced in mice upon immunization with
200 mg of MOG-35-55 peptide (MEVGWYRSPFSRVVH-
LYRNGK, NeoMPS) in emulsion with CFA (Sigma) 1:1 by
volume containing 800 mg of non-viable desiccated Mycobacteri-
um tuberculosis H37RA (Difco Laboratories). A total volume of
200 ml was injected subcutaneously at 4 sites over the flanks. In
addition, 300 ng of pertussis toxin (List Biological Laboratories)
was given intravenously on the same day and 2 days later. The
grid for the assessment of the clinical progression of EAE was
adopted from Strommes et al. [4]. The grid is as follows: 0, no
signs; 0.5, partially limp tail; 1, paralyzed tail; 2, hind limb paresis;
2.5, one hind limb paralyzed; 3, both hind limbs paralyzed; 3.5,
weakness in forelimbs; 4, forelimbs paralyzed; 5, moribund.
Adoptive transfer of CD8+ T cells
CD8+ T cells were negatively enriched from the draining lymph
nodes of immunized mice using a CD8+ T cell enrichment kit (BD
Bioscience, 558471). CD8+ T cell purity was confirmed to be
more than 90%. Three or four million purified CD8+ T cells from
two mice were injected retro-orbitally into one naı ¨ve recipient
mouse.
Isolation of lymphoid cells
Cells from the spleen and lymph nodes were isolated by
meshing the organs through a 100 mm filter. The red blood cells in
the splenocyte suspension were lysed with ACK lysis buffer. The
brain and spinal cord were dissected out and meshed as above.
The mononuclear cells were isolated on a 37.5% percoll (Sigma
P1644) gradient and suspended in 200 ml of PBS-2% FCS.
Antibodies and reagents
Monoclonal antibodies specific for CD4 (clone RM4-5), CD8
(clone 53–6.7) and CD3 (clone 145-2C11) at a concentration of
2 mg/ml were used in this study. MOG-specific cells were
identified using MOG38–48-I-A
b tetramers at a concentration of
4 mg/ml for 20 h at 37uC. Absolute numbers of cells in 200 ml
suspensions were calculated using Beckman CoulterH Flowcount
fluorospheres (ref 7547053) as a standard. Flow cytometric
acquisition was performed using a BD LSRII and the data were
analyzed using BD Diva software.
Statistics
Results are expressed as means 6 SEM. Differences between
groups were evaluated by one-way ANOVA with Fischer’s post-
hoc tests, or by Mann-Whitney non-parametric tests, as appro-
priate. Differences between groups were considered significant
when the P value was ,0.05. Analysis was performed using
Statview 5.0 Software (SAS Institute Inc., USA).
Results
Primary in vivo T cell activation inhibits subsequent CD4+
T cell responses belonging to the same Vß family
Studies on TCV have demonstrated that vaccination of mice
using ex vivo activated and attenuated Vß8.2+CD4+ T cells
protects mice from MOG-specific Vß8.2+CD4+ T cell-induced
EAE [5]. We hypothesized that the endogenous activation of
Vß8.2+CD4+ T cells might trigger a protective effect similar to
that induced by the vaccinating T cells during TCV. Immuniza-
tion with a peptide derived from the Pigeon Cytochrome C (PCC),
a model non-self antigen in our studies, induces the activation of
PCC-specific CD4+ T cells belonging predominantly to the Vß8.2
family [6,7]. We thus immunized mice with either PCC or a
control peptide derived from ovalbumin (OVA) that induces a
Vß5+ CD4+ T cell response. Three weeks later, the mice were
immunized with MOG to induce EAE. The disease course was
followed by the development of paralysis. Mice that were
previously immunized with PCC were completely protected from
disease development. Importantly, all the mice immunized with
OVA succumbed to EAE with normal kinetics of disease evolution
as compared to the control mice (Figure 1). Thus, a previous
activation of endogenous Vß8.2+CD4+ T cells specific for a non-
self antigen - but not Vß5+CD4+ T cells - protects mice from anti-
MOG Vß8.2+CD4+ T cell-mediated EAE development.
Sustained CD8+ T cell activation is required for
Vß-specific T cell suppression
Vß-specific protection observed in our experimental set-up is
akin to the protection induced upon injection of the vaccinating
clones during TCV. Since CD8+ T cells possess an essential role in
TCV-mediated protection [2], we questioned whether the Vß-
specific protection observed in our model was also dependent on
CD8+ T cells. To address this question, naı ¨ve mice were
immunized with PBS or PCC. Three weeks later, CD8+ T cells
purified from the draining lymph nodes and the spleen were
adoptively transferred to naı ¨ve recipients. Sixteen hours later, EAE
was actively induced in the recipients by immunization with
MOG. Mice that received CD8+ T cells from PCC-immunized
mice showed delayed signs of EAE development as compared to
control mice that received CD8+ T cells from PBS-immunized
mice (Figure 2A). The observation that the protection conferred by
the CD8+ T cell transfer was of a lower magnitude than that
observed in the initial experiments suggested that regulatory
CD8+ T cells might need to be sustained to be effective. Indeed,
the first experimental design where the two sequential immuni-
zations were performed in the same mouse most likely favored the
continuous generation or maintenance of regulatory CD8+ T cells
due to the persistence of the first anti-PCC CD4+ T cell response.
In an independent experiment, we therefore performed 2
consecutive adoptive transfers of CD8+ T cells: the first one was
performed the day before EAE induction as in the initial
experiment and the second, 7 days later. The development of
Peripheral Induction of Regulatory CD8+ T Cells
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CD8+ T cells from PCC-immunized mice as compared to control
mice (Figure 2B) suggesting that continuous Vß-specific CD8+ T
cell generation or maintenance is required for the suppression of
CD4+ T cell-mediated autoimmunity. The Vß-specific protection
triggered by the first CD4+ T cell response is hence CD8+ T cell-
dependent and is reminiscent of observations made in CD8+ T
cell-deficient mice in which secondary T cell activation is
unrestrained [8].
Control of T cells by ‘naturally’-induced regulatory CD8+
T cells is Qa-1-dependent
Our experiments illustrate that CD8+ T cells induced upon
antigen-induced CD4+ T cell activation are specific for a
particular Vß chain as the endogenous activation of CD4+Vß5+
T cells failed to confer protection against anti-MOG Vß8.2+CD4+
T cell-mediated EAE. Prior studies have demonstrated that
peptides derived from the Vß chain are presented by Qa-1 on
vaccinating T cells used during TCV [9,10]. We investigated
whether activated T cells specific for non-self antigens may also be
capable of presenting Vß peptides in the Qa-1 molecule that
would induce regulatory CD8+ T cells. CD8+ T cells from PCC-
or control PBS-immunized mice were adoptively transferred to
naı ¨ve Qa-1-deficient or wildtype mice. EAE development upon
primary immunization with MOG in Qa-1-deficient mice has
been demonstrated to follow disease kinetics comparable to
wildtype mice [3]. As observed before (Figure 2), wildtype mice
that received CD8+ T cells from PCC-immunized mice were
protected during the preliminary stages of EAE development as
compared to control mice (Figure 3). Interestingly, Qa-1-deficient
Figure 1. Immunization with PCC protects mice from EAE. A. Experimental design and hypothesis. C57BL/6 mice were immunized with either
50V PCC-derived peptide that induces a Vß8.2+CD4+ T cell response or an OVA-derived peptide that induces a Vß5+CD4+ T cell response. It is
expected that the first T cell responses induce corresponding anti-Vß8.2 and anti-Vß5 CD8+ regulatory T cell responses. In order to test this
hypothesis, mice were submitted to a second immunization with MOG. Encephalitogenic Vß8.2+ anti-MOG T cells would be controlled only by anti-
Vß8.2 CD8+ T cells induced by the first antigenic challenge. In this experimental design, the control of self-reactive T cells is therefore reflected in the
control of EAE development. B. Naive C57BL/6 mice were immunized subcutaneously with PBS (n=7, squares), 100 mg of a 50V PCC-derived peptide
(PCC, triangles, n=5), or 100mg of an OVA-derived peptide (OVA, circles, n=7) in CFA. Three weeks later, EAE was actively induced by subcutaneous
immunization with MOG35-55 peptide and intravenous pertussis toxin (300 ng) injections on the day of induction and 2 days later. The clinical course
of EAE was analyzed using a paralysis grading score over 30 days. Representative of 2 independent experiments. Mean 6 SEM. * indicates that the p-
value,0.001 as assessed using ANOVA Fisher’s PLSD.
doi:10.1371/journal.pone.0021628.g001
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immunized donors were not protected from EAE development
indicating that CD8+ T cell-mediated control required Qa-1
presentation on activated CD4+ T cells (Figure 3). These
experiments indicate that CD4+ T cells induced upon pathophys-
iological antigen-induced activation are able to present Vß-
peptides in their Qa-1 molecule thus enabling the generation of
regulatory anti-Vß CD8+ T cells, which in turn recognize similar
Qa-1-Vß peptide complexes on self-reactive CD4+ T cell and
suppress their function.
Regulatory CD8+ T cells diminish lymphocyte infiltration
into the CNS
Active EAE development is associated with an infiltration of
inflammatory lymphocytes in the central nervous system (CNS).
The protection observed upon CD8+ T cell transfer from PCC-
immunized mice was associated with a reduction in the number of
lymphocytes in the CNS as compared to control mice (Figure 4A).
Anti-MOG CD4+ T cells primed in the periphery migrate
through the blood-brain barrier essentially by chemotaxis [11].
Once infiltrated these cells secrete pro-inflammatory cytokines
such as IFNc and IL-17 that trigger the inflammatory response
facilitating myelin destruction. In our studies, the percentage of
MOG-specific CD4+ T cells detected by tetramer staining was
also diminished in the CNS of protected mice (Figure 4B).
Correspondingly, in the CNS of protected mice we also observed a
drastic diminution of IL-17-secreting CD4+ T cells (Figure 4C)
and of IFNc-secreting cells indicating the control of inflammation
in the CNS of these mice (Figure 4D).
Discussion
Regulatory Qa-1-restricted CD8+ T cells can be induced by the
TCV - T cell vaccination -procedure that involves the injection of
activated, attenuated, CD4+ T cells. The main result of the
present study is the demonstration that similar regulatory cells can
specifically be triggered upon the activation of endogenous T cells.
Indeed, our data indicate that antigen-stimulated CD4+ T cells
induce regulatory CD8+ T cells that recognize Vßx-derived
peptides presented in the Qa-1 molecule on CD4+ T cells. Similar
to TCV, regulatory CD8+ T cells could target CD4+ T cells with
distinct antigenic specificity as long as they expressed a TCR with
the same Vß chain. Indeed, secondary T cell responses involving T
cells with Vß chains distinct from those activated during the
primary response developed completely unrestricted, as demon-
strated by our experiments performed with ovalbumin. In this
case, the Qa-1-restricted CD8+ T cells elicited by anti-OVA Vß5
CD4+ T cells failed to control the encephalitogenicVß8.2 CD4+ T
cells. In addition, the primary CD4+ T cell response occurred
unhampered, indicating that regulatory CD8+ T cells do not affect
primary immune responses. We propose that regulatory CD8+ T
cells are induced at a later stage of the immune response during
which, to the best of our knowledge, no regulation has yet been
Figure 2. CD8+ T cells from PCC immunized mice protect naı ¨ve
mice from EAE. A. Naı ¨ve C57BL/6 mice were immunized with PBS or
100mg of 50V PCC in CFA. Three weeks later, CD8+ T cells purified from
the draining lymph nodes and spleen of the PBS immunized (CD8 PBS,
squares) or PCC immunized (CD8 PCC, triangles) mice were adoptively
transferred into naı ¨ve C57BL/6 recipients (CD8 PBS n=10, CD8 PCC
n=10). Sixteen hours later, EAE was induced in the recipients upon
subcutaneous immunization with MOG peptide accompanied by
intravenous pertussis toxin on the day of EAE induction and 2 days
later. B. Similar protocol was carried out with a second transfer of CD8+
T cells 9 days after EAE induction. The clinical course of EAE was
analyzed using a paralysis grading score. Mean 6 SEM. * indicates that
the p-value,0.05 as assessed using ANOVA Fisher’s PLSD. Arrows
indicate the time points of CD8+ T cell transfer.
doi:10.1371/journal.pone.0021628.g002
Figure 3. Regulatory CD8+ T cells are restricted to Qa-1. Naı ¨ve
C57BL/6 mice were immunized with PBS or 100mg of 50V PCC in CFA.
Three weeks later, CD8+ T cells purified from the draining lymph nodes
and spleen of PBS-immunized (CD8 PBS) and PCC-immunized (CD8
PCC) mice were adoptively transferred into either wildtype (WT, n=7
for ‘CD8 PBS in WT’ and ‘CD8 PCC in WT’) or Qa-1-deficient mice (Qa-1u,
n=5 for ‘CD8 PBS in Qa-1u’ and n=6 for ‘CD8 PCC in Qa-1u’). EAE was
induced in the recipients 16 hours later. * indicates that the p-
value,0.05 as assessed using ANOVA Fisher’s PLSD.
doi:10.1371/journal.pone.0021628.g003
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T cell responses frequently entrail the release of a variety of T cell
mediators that are not only efficient in the elimination of foreign
antigens but can also destroy self tissue. After the essential primary
response, the immediate re-initiation of inflammatory secondary
responses could lead to drastic and permanent tissue damage.
Induction of regulatory CD8+ T cells might hence limit tissue
damage caused by constant re-activation of T cell responses when
the specific antigen persists. Interestingly, studies on TCV-induced
regulatory Vß-specific CD8+ T cells have shown that these cells
are capable of specifically targeting inflammatory Th1 CD4+ T
cells [9]. In our studies, we have shown that regulatory Qa-1-
restricted CD8+ T cells are able to limit the secretion of IFN-c
from cells of the CNS and also to control CNS-infiltrating
inflammatory IL-17-secreting CD4+ T cells, thus preventing tissue
damage.
A corollary question concerns the site where Qa-1-restricted
CD8+ T cells do exert their control over CD4+ T cells. The
expression of Qa-1 on activated CD4+ T cells increases with time
(unpublished personal observation). Vaccinating T cells used
during TCV require stimulation for at least 40 hours before
vaccination indicating a necessity for optimal surface expression of
Qa-1-Vß peptide complexes [12]. Thus, for control by Vß-specific
Qa-1-restricted regulatory CD8+ T cells, self-reactive CD4+ T
cells need to be optimally activated. Given that activated CD4+ T
cells exit reactive lymph nodes 72-96 hours after interaction with
antigen presenting cells [13], we can assume that regulatory CD8+
T cells either control activated self-reactive T cells in the
secondary lymphoid tissues or co-migrate to the target tissue (the
CNS in our case) and control T cell function. The lack of tissue
destruction upon transfer of protective CD8+ T cells together with
the absence of inflammatory leukocytes in the CNS indicates that
CD4+ T cells were probably not able to attain the CNS and cause
inflammation. Such evidence suggests that regulatory CD8+ T
cells control activated self-reactive CD4+ T cells in the reactive
lymph node. In support of these findings, our recent data indicate
that Qa-1-restricted anti-ergotypic CD8+ T cells are able to
proliferate and control T cell responses in secondary lymphoid
organs [14]. The recent finding by the group of Cantor [15]
showing that Qa-1-restricted CD8+ T cells can control follicular
helper T cells further indicates that the point of control of these
regulatory cells is located in secondary lymphoid organs.
The fact that, in a physiopathological situation, regulatory
CD8+ T cells could sequentially target CD4+ T cells with distinct
antigen specificities, provided that they express a TCR with the
same Vß chain, raises unforeseen questions. There exist 25
Figure 4. Regulatory CD8+ T cells prevent lymphocyte infiltration and CNS inflammation. Naı ¨ve mice were adoptively transferred with
CD8+ T cells from PBS-immunized (CD8 PBS, n=4) or PCC-immunized (CD8 PCC, n=4) mice followed by EAE induction 16 hours later. Thirteen days
after EAE induction, the mice were sacrificed and the lymphocyte populations in the brain and spinal cord were examined by flow cytometry. A.
Absolute numbers of lymphocytes in the CNS gated according to their forward and side-scatter characteristics. B. MOG-specific CD4+ T cells were
stained using MOG38–49-I-Ab tetramers. Represented is the percentage of tetramer-positive cells among total CD4+ T cells in the CNS. C. Absolute
numbers of CD4+ T cells that produce IL-17 in the CNS. D. Absolute numbers of IFNc-producing CD4+ T cells in the CNS. Mean 6 SEM. * indicates that
the p-value,0.05 as assessed using Mann-Whitney non-parametric analysis.
doi:10.1371/journal.pone.0021628.g004
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alone in its TCR. The establishment of a Vß specific regulatory
system would thus allow the control of 1/25th of CD4+ T cells.
One could argue that if these regulatory Qa-1-restricted CD8+ T
cells become memory cells, secondary CD4+ T cell responses
might be paralyzed after few primary CD4+ challenges, each with
a distinct Vß chain. Since this is evidently not the case, we
anticipate that the regulatory Qa-1-restricted CD8+ T cells are
short-lived cells. Future studies are warranted to specifically
address this issue.
Another important finding of our study is that Vßx-specific Qa-
1-restricted CD8+ T cells induced upon CD4+ T cell responses
against a non-self antigen were capable of controlling the
activation of self-reactive Vßx+ T cells. Thus, our data point at
a crucial role for CD4+ T cell responses against non-self antigens
in the maintenance of an efficient peripheral regulatory Qa-1-
restricted CD8+ T cell repertoire that can control the expansion of
autoreactive T cells such as those involved in the EAE model.
In order to analyze the nature of the Vß sequences capable of
binding Qa-1, we performed in silico alignments of the known
repertoire of peptides (Figure 5) shown to bind Qa-1: peptides
derived from the MHC class I-leader sequence [16], pre-
proinsulin [17,18] and Heat Shock Protein (HSP) 60 [19]. This
revealed a consensus sequence (Figure 5B) that we searched for in
complete mouse Vß chain sequences. We found candidate
peptides in each Vß chain with this consensus pattern
(Figure 5C). These Vß sequences not only possess the chemically
and structurally defined consensus sequence of all known Qa-1
binding peptides but were also highly hydrophobic, a property
common to MHC-leader sequences, making them ideally suited to
bind Qa-1 that, like its human orthologue HLA-E, has a
substantially hydrophobic peptide binding groove [20].
Most intriguingly, similar to the MHC/HLA leader sequence
peptides, all the Vß peptides elucidated by sequence alignment
mapped to the leader sequence of the TCR Vß chains (Figure 5C).
Similar peptide sequences were also found in the leader sequences
of human Vß chains (data not shown). Interestingly, these 9 aa-
long sequences are considerably distinct from one another, an
absolute requirement to allow Qa-1-restricted CD8+ T cells to
distinguish each Vß peptide and to endow them with the capacity
to specifically control CD4+ T cells according to their Vß chains.
Indeed, Qa-1 and HLA-E might have evolved to preferentially
bind peptides derived from leader sequences of membrane or
secreted proteins. Upon recognition of their cognate peptide, T
cells upregulate TCR expression, which requires the synthesis of
new Vß chains, and hence, the release of free leader sequences.
Thus, once in the MHC-peptide loading compartments, peptides
derived from Vß leader sequences would compete with MHC
leader sequences to bind Qa-1. Upon clonal T cell activation, the
large number of T cells capable of expressing similar Qa-1-Vß
peptide complexes would further favor the expansion of specific
CD8+ T cells. However, recent studies have shown that Vß chain
peptides that do not map to the leader sequence can induce a Qa-
1-restricted CD8+ T cell response [21]. In these studies, Qa-1 was
loaded with synthetic peptides from Vß CDR2 regions [21] or by
cross-presentation of TCR-derived peptides upon processing of
apoptotic CD4+ T cells by bone marrow-derived dendritic cells
[22]. These data suggest that Qa-1-restricted CD8+ T cells can
recognize distinct peptide repertoires according to the antigen-
presenting cells. Our data suggest that in the case of activated
CD4+ T cells, the Qa-1 molecule would preferentially present
peptides derived from leader sequences of TCR Vß chains.
Our results demonstrate that a complementary, adapted,
regulatory response is induced upon T cell responses against
non-self antigens. We can anticipate that in individuals that mount
few adaptive immune responses, due to infrequent antigen
exposure, this type of regulation might be poorly developed
thereby allowing the peripheral expansion of pathogenic self-
reactive T cells. On the other hand, these regulatory CD8+ T cells
could impair effective T cell responses during vaccination
strategies. Further studies on the half life and mechanism of
control of these regulatory CD8+ T cells would be fruitful to the
understanding of differential responses of individuals to infections
and vaccinations.
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Figure 5. Qa-1-binding molecular pattern. A. The alignment of
previously described 9 amino acid-long Qa-1-binding peptides (Qdm,
pre-proinsulin, HSP60 signal sequence derived peptide) using the
Geneious software (ClustalW analysis). B. A consensus sequence with
conserved amino acids in position (P) 1, 2, 5, 7 and 9 was revealed from
this alignement. C. The search of such a consensus sequence in mouse
Vß chains derived from the IMGT database revealed the presence of
consenting 9 amino acid long peptides in the leader sequences of all
mouse Vß chains. * Described as being a Qa-1-binding peptide in ref
[12].
doi:10.1371/journal.pone.0021628.g005
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